Vitruvian Partners LLP

CIK 0001692590 · LONDON, null · Quarter end: 2026-06-30 · Filed on: 2026-08-10 · Open the SEC source ↗

Vitruvian Partners LLP reported 8 positions worth $201.0M as of June 30, 2026 (13F filed August 10, 2026). Largest holding: MARQETA INC (55.4%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.

$201.0M

2026 Q2

Positions

Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.

100.0%

Est. Net Flow (Q)

—

2026 Q2

Positions Changes Mix History BacktestPRO

8 positions shown

#	Symbol	Company	Type	Value ↓	% Port.	Shares	1Y	YTD
▸ 1	57142B104	MARQETA INC	SH	$111.3M	55.38%	6,853,183	—	—
▸ 2	HNGE	HINGE HEALTH INC	SH	$42.0M	20.92%	506,599	—	—
▸ 3	XMTR	XOMETRY INC	SH	$17.5M	8.70%	181,169	—	—
▸ 4	CARG	CARGURUS INC	SH	$11.9M	5.94%	350,044	—	—
▸ 5	GLBE	GLOBAL E ONLINE LTD	SH	$7.3M	3.63%	210,209	—	—
▸ 6	MXCT	MAXCYTE INC	SH	$6.2M	3.09%	5,043,356	—	—
▸ 7	WSE	WISE GROUP PLC	SH	$3.4M	1.67%	281,277	—	—
▸ 8	RXST	RXSIGHT INC	SH	$1.3M	0.67%	278,865	—	—

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Vitruvian Partners LLP hold as of Q2 2026?

Vitruvian Partners LLP reported 8 positions worth $201.0M in its Q2 2026 13F filing. Largest positions: MARQETA INC (55.4%), HNGE (20.9%), XMTR (8.7%), CARG (5.9%) and GLBE (3.6%).

What did Vitruvian Partners LLP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Vitruvian Partners LLP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.